Recruiting
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
NCT03618550
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +12 more
- Locations
-
- City of Hope Cancer Center (Data Collection Only) Duarte, California, United States
- Stanford University Medical Center Stanford, California, United States
- University of Miami Miami, Florida, United States
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States